THYROID CANCER (FOLLICULAR CELL)

Clinical trials for THYROID CANCER (FOLLICULAR CELL) explained in plain language.

Never miss a new study

Get alerted when new THYROID CANCER (FOLLICULAR CELL) trials appear

Sign up with your email to follow new studies for THYROID CANCER (FOLLICULAR CELL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Scientists try drug duo to Re-Sensitize stubborn thyroid tumors

Disease control Completed

This early-stage study tested a combination of two drugs, vemurafenib and copanlisib, in patients with a specific type of advanced thyroid cancer that had stopped responding to standard radioactive iodine therapy. The main goals were to find the safest dose of the drug combinatio…

Matched conditions: THYROID CANCER (FOLLICULAR CELL)

Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

THYROID CANCER (FOLLICULAR CELL)

Get alerted when new THYROID CANCER (FOLLICULAR CELL) trials appear

Scientists try drug duo to Re-Sensitize stubborn thyroid tumors